ARCHIVES

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 30 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December

September 19, 2014

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

Sens. Kennedy, Hutchison To Introduce Bill On Cancer Research, Care.

May 9, 2008

No Cancer Letter For Next Two Weeks

August 30, 1991

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989